FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:1267-1275 March 27, 2003 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Presentation of Case

A 72-year-old man was transferred to this hospital from another hospital because of rapidly progressive leukemia and multiorgan failure.

The patient had lost an unknown amount of weight during the preceding two months, but he was considered to be in stable condition, with mild chronic renal failure (creatinine level, 1.9 mg per deciliter [168 µmol per liter] nine months before admission). Twenty-three days before admission, laboratory studies were performed at another hospital in preparation for an elective transurethral resection of the prostate gland (Table 1 and Table 2).

View this table: [in this window] [in a new window]   Table 1. Hematologic Laboratory Values.

 

View this table: [in this window] [in a new window]   Table 2. Blood Chemical Values.

 
Two weeks before admission, . . . [Full Text of this Article]

Differential Diagnosis

Lymphadenopathy and Lymphocytosis

Hypercalcemia

HTLV-I–Associated Adult T-Cell Leukemia–Lymphoma

Infectious Complications in Adult T-Cell Leukemia–Lymphoma

Other Lymphoproliferative Disorders in Adult T-Cell Leukemia–Lymphoma

Summary

Clinical Diagnosis

Dr. Francine M. Foss's Diagnosis

Pathological Discussion

Anatomical Diagnosis

Source Information

From the Department of Hematology/Oncology, New England Medical Center, and the Department of Medicine, Tufts University Medical Center (F.M.F.); and the Departments of Radiology (S.L.A.) and Pathology (J.A.F.), Massachusetts General Hospital and Harvard Medical School — all in Boston.

This article has been cited by other articles:

• Richardson, S., Budgin, J. B., Junkins-Hopkins, J. M., Vittorio, C. C., Lee, J., Miller, W. T. Jr, Rook, A. H., Kim, E. J. (2005). Low-Dose Bexarotene and Low-Dose Interferon Alfa-2b for Adult T-Cell Leukemia/Lymphoma Associated With Human T-Lymphotropic Virus 1. Arch Dermatol 141: 301-304 [Full Text]